China Feihe Limited

China Feihe Limited

CFEIY
China Feihe LimitedUS flagOther OTC
4.39
USD
- -
- -
3.98BMarket Cap
China Feihe Limited
CFEIY
(Other OTC)

Recent

price

4.39

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
4.17
6.59
11.63
16.82
20.81
25.53
23.83
21.56
22.93
20.07
Revenue per Share
0.47
1.3
2.51
4.82
8.32
7.7
5.53
3.74
3.95
2.15
Basic EPS, GAAP
0.02
1.86
2.05
4.42
7.75
6.01
5.29
3.84
3.82
1.48
Free Cash Flow per Basic Share
- -
- -
- -
3.31
3.01
3.8
2.38
2.82
2.87
2.49
Dividend per Share
- -
- -
5.3
7.23
11.77
15.57
18.65
19.31
20.75
20.46
Book Value per Share
2.6
3.96
6.42
15.91
21.42
24.96
28.34
28.92
30.15
28.81
Tangible Book Value per Share
893
893
893
816
893
892
894
906
905
902
Basic Weighted Avg Shares
3,724
5,887
10,392
13,722
18,592
22,776
21,311
19,532
20,749
18,113
Sales/Revenue/Turnover
19.22
26.28
30.69
40.62
43.38
41.66
31.77
26.45
26.83
19.29
Operating Margin (%)
99
98
162
181
263
443
494
608
649
514
Depreciation Expense
417
1,160
2,242
3,935
7,437
6,871
4,942
3,390
3,570
1,939
Net Income, GAAP
31.73
29.73
29.68
30.76
24.89
28.51
25.74
32.16
34.16
37.54
Effective Tax Rate (%)
11.2
19.71
21.58
28.67
40
30.17
23.19
17.36
17.21
10.71
Profit Margin (%)
975
1,333
2,434
9,850
11,437
13,028
14,770
15,172
15,658
13,508
Working Capital
- -
64
792
1,845
871
737
988
1,044
539
250
LT Debt
2,377
3,585
5,787
13,030
19,186
22,403
25,475
26,334
27,407
26,121
Total Equity
- -
27.43
34.48
28.84
30.18
29.43
19.33
12.58
12.83
7.76
Return on Invested Capital (%)
- -
156.59
59.82
45.38
61.6
45.86
27.44
17.54
16.8
8.53
Return on Capital (%)
- -
116,022,600
94.76
74
90.59
56.29
32.33
19.84
19.69
10.42
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
6.65%
-4.69%
Free Cash Flow
- -
-24.58%
-61.33%
Net Income, GAAP
- -
-21.49%
-45.68%
Sales/Revenue/Turnover
- -
0.25%
-12.7%
Total Cash Common Dividend
- -
-0.56%
-13.58%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
19,532
2024
- -
- -
- -
- -
20,749
2025
- -
- -
- -
- -
18,113

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
3.74
2024
- -
- -
- -
- -
3.95
2025
- -
- -
- -
- -
2.15

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
2.82
2024
- -
- -
- -
- -
2.87
2025
- -
- -
- -
- -
2.49
Business
China Feihe Limited China Feihe Limited (Ticker: CFEIY), an investment holding company incorporated in the Cayman Islands, engages in the production and sale of dairy products, raw milk, and nutritional supplements primarily in Mainland China, with operations extending to Canada and the United States. The company offers a diversified portfolio of infant milk formula products designed to mimic the composition of Chinese breast milk, including super-premium brands such as Astrobaby, Astrobaby A2, Super-Premium Organic Zhenzhi, Super-Zhuorui, Organic Chunrui, and premium lines like Zhenai Beihu, OPremium Zhenai Feifan, Xingjie Youhu, Feifan, Miao Shu Huan, and Zhouran; adult milk powders; liquid milk products; soybean powder; rice powder supplements; and health care products including vitamins, minerals, herbs, and nutritional supplements retailed through Vitamin World USA. Founded in 1962 and headquartered at Star City International Building in Beijing, China, the company distributes its products via an extensive nationwide network of over 2,800 offline distributors covering more than 80,000 retail points including maternity stores, supermarkets, and hypermarkets, as well as e-commerce platforms, its own website, and mobile applications, with infant formula comprising approximately 90% of sales. China Feihe Limited maintains 11 production facilities with a total annual capacity exceeding 363,000 tonnes, including recent expansions in liquid milk production; it obtained its first infant formula production license in Canada in April 2024 and continues share repurchases, such as 20 million shares in November 2025 and ongoing subscriptions to low-risk financial products from SPD Bank totaling RMB2.2 billion as of October 2025 to optimize idle funds.

Company News

APIChatGPT
  • China Feihe (OTCMKTS:CFEIY) Trading Down 9.8% – What’s Next?

  • China Feihe downgraded to Neutral from Buy at Goldman Sachs

  • China Feihe downgraded to Neutral from Buy at Goldman Sachs

  • China Feihe downgraded to Neutral from Buy at Goldman Sachs

  • The 3 Most Undervalued Stocks Under $1 to Buy Now: August 2023